Azerbaijan vs Republic of Moldova: Hepatitis B surface antigen (HBsAg) prevalence
Azerbaijan
0.3%
in 2024
Republic of Moldova
0.3%
in 2024
Azerbaijan rank
71st
Republic of Moldova rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Azerbaijan
- Republic of Moldova
How they compare
Azerbaijan currently reports 0.3% against 0.3% in Republic of Moldova, a difference of 0.0%.
Across all 10 years both countries report, Republic of Moldova has been ahead every year.
Azerbaijan ranks 71st and Republic of Moldova ranks 71st of 194 countries.
Republic of Moldova has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Azerbaijan | Republic of Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.4% | 0.2% | Republic of Moldova |
| 2020s | 0.3% | 0.3% | 0.1% | Republic of Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Azerbaijan or Republic of Moldova?
- Azerbaijan, at 0.3% against 0.3% in Republic of Moldova as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Azerbaijan and Republic of Moldova?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Republic of Moldova?
- 10 years are reported by both, from 2015 to 2024.
- How do Azerbaijan and Republic of Moldova rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Azerbaijan ranks 71st and Republic of Moldova ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.